pxlence

Stationsstraat 30A

9200 Dendermonde

BE

pxlence

Foundation date

05/02/2015

Sector

#Biotechnology - Therapeutics

Subsector

pxlence is a medical technology company developing and manufacturing PCR assays and kits for targeted resequencing or nucleic acid quantification.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    13 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024